The European Federation of Pharmaceutical Industries and Associations has called on governments and policymakers throughout Europe "to use the financial crises as a real opportunity to make health care systems fit for the 21st century, and not as yet another excuse for cutting health and pharmaceutical expenditure."
"Immense pressure" on public budgets
The EFPIA noted that IMS Health forecasts for the global health care market have dropped significantly to 2.5%-3.5% on a constant-dollar basis in 2009 (Marketletter April 27), down two percentage points from the 4.5%-5.5% level indicated last year (Marketletter November 10, 2008). The drugmaker's group commented that "the severity of the economic downturn is putting public budgets under immense pressure and this could affect patient access to new medicines as well as the pharmaceutical sector's competitiveness and ability to fund future research."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze